We are currently recruiting healthy participants for a research study that examines learning and memory of a fine motor skill. If you choose to participate, you will visit the laboratory for two consecutive days, for 30-60 minutes each day. During these sessions, you will complete a fine motor task repeatedly. If you are interested, please contact Sara at email@example.com
Sara at firstname.lastname@example.org
We are currently recruiting healthy participants who consume less than 500mg of caffeine per week for a research study that examines the effect of caffeine on motor memory. If you choose to participate, you will be assigned to one of two groups: one group will receive a caffeine pill after learning a new motor skill, and another group will receive a placebo pill after learning a new motor skill. All subjects will visit the laboratory for two consecutive days, for 30-60 minutes each day. During these sessions, you will complete a fine motor task repeatedly. If interested, please contact Sara at email@example.com
Aspire A Postmarketing Observational Study to Assess Respiratory Tract Adverse Events in Pulmonary Arterial Hypertension Patients Treated With Tyvaso®(Treprostinil) Inhalation Solution
Primary Outcome Measures: Describe the type and incidence of oro-/nasopharyngeal and pulmonary adverse events that may be associated with current or recent treatment with Tyvaso for PAH and with patients not treated with Tyvaso for PAH.
Please refer to www.clinicaltrials.gov for more information identifier NCT01266265
Pulmonary Hypertension Program
Cynthia Larew RN 319-356-1028 pager # 2123
The purpose of this study is to demonstrate that the results achieved in the original pivotal clinical investigation of 81 subjects from five clinical sites are generalizable to new clinical sites that complete the staff training defined in the SynCardia Systems, Inc. Training Manual and who enroll subjects who meet the intended use defined in the product Instructions for Use.
Please refer to www.clinicaltrials.gov identifier NCT00614510 for more information.
Cardiomyopathy Treatment Program
Page Scovel, RN
Participants in this research study have been diagnosed with advanced stage non-small cell lung cancer and are currently receiving chemotherapy. The purpose of this study is to determine the safety of a drug called darbepoetin alfa. Approximately 3000 people will be enrolled in this study worldwide. Study involvement will last until the conclusion of the study.
Karen Parrott, 319-353-6347
Please help us improve your experience on our website by completing a brief survey
Yes, I'll give feedback No, Thanks
Your browser does not support iframes.